One Target at a Time with Clay Siegall

Clay Siegall is the co-founder of a company called Seattle Genetics. The company was created in 1998. The goal of this firm is to develop targeted drugs for diseases that have a very high mortality rate. Clay Siegall has worked previously for Bristol-Meyers Squibb and the National Institutes of Health. In an interview with inspirery.com…